A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis.

Fujimoto, Mutsumi; Kobayashi, Yoshie; Kuraoka, Kazuya; Yoshiyama, Tomoyuki; Shigematu, Hideo

Fujimoto, Mutsumi; Kobayashi, Yoshie; Kuraoka, Kazuya; Yoshiyama, Tomoyuki; Shigematu, Hideo.

Afiliación

Fujimoto M; Department of Breast Surgery, Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-Cho, Kure, Hiroshima, 737-0023, Japan. mu.fujimoto.12@gmail.com.
Kobayashi Y; Department of Breast Surgery, Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-Cho, Kure, Hiroshima, 737-0023, Japan.
Kuraoka K; Department of Diagnostic Pathology, Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-Cho, Kure, Hiroshima, 737-0023, Japan.
Yoshiyama T; Department of Breast Surgery, Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-Cho, Kure, Hiroshima, 737-0023, Japan.
Shigematu H; Department of Breast Surgery, Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-Cho, Kure, Hiroshima, 737-0023, Japan.

Surg Case Rep ; 9(1): 209, 2023 Dec 01.

Article en En | MEDLINE | ID: mdl-38036933

Palabras clave

CA15-3; DCIS; Tumor marker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Surg Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google